This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flaherty, J. F. Articles by Gambertoglio, J. G. Search for Related Content PubMed PubMed Citation Articles by Flaherty, J. F., Jr Articles by Gambertoglio, J. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1996, 1134-1138, Vol 40, No. 5
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Protein binding of clindamycin in sera of patients with AIDS

JF Flaherty Jr, G Gatti, J White, J Bubp, M Borin and JG Gambertoglio
Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco 94143-0622, USA. jffj@itsa.ucsf.edu

Patients with AIDS have altered pharmacokinetics of clindamycin compared with those of healthy control subjects. In an attempt to better understand these differences, we undertook a study of protein binding of clindamycin in sera of patients with AIDS. Fifteen patients with AIDS and 15 healthy volunteers were given a single 600-mg dose of clindamycin orally and intravenously, and serum samples were collected at three time points corresponding to high, midpoint, and low clindamycin concentrations. Protein binding was determined by ultrafiltration, and total and unbound clindamycin concentrations were measured with a gas chromatography assay. AIDS patients had alpha 1- acid glycoprotein values approximately twice those of healthy volunteers (mean +/- standard deviation, 103 +/- 27 versus 61 +/- 11 mg/dl; P = 0.001). Overall, serum protein binding levels were higher in AIDS patients (mean +/- standard deviation, 83 +/- 7 versus 78% +/- 8%; P = 0.0001), which is likely the result of increased alpha 1-acid glycoprotein levels in these patients. Total concentrations of clindamycin in plasma were significantly higher in AIDS patients at most time points studied, while unbound serum clindamycin concentrations did not differ among the groups at each sampling time after both oral and intravenous dosing. Increased protein binding may partly explain the altered pharmacokinetic disposition of clindamycin in AIDS patients; however, other factors cannot be excluded.

This article has been cited by other articles:

• Holladay, J. W., Dewey, M. J., Michniak, B. B., Wiltshire, H., Halberg, D. L., Weigl, P., Liang, Z., Halifax, K., Lindup, W. E., Back, D. J. (2001). Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir. Drug Metab. Dispos. 29: 299-303 [Abstract] [Full Text]  
• Lewis, R. E., Klepser, M. E., Ernst, E. J., Lund, B. C., Biedenbach, D. J., Jones, R. N. (1999). Evaluation of Low-Dose, Extended-Interval Clindamycin Regimens against Staphylococcus aureus and Streptococcus pneumoniae Using a Dynamic In Vitro Model of Infection. Antimicrob. Agents Chemother. 43: 2005-2009 [Abstract] [Full Text]  
• Arredondo, G., Suarez, E., Calvo, R., Vazquez, J. A., Garcia-Sanchez, J., Martinez-Jorda, R. (1999). Serum protein binding of itraconazole and fluconazole in patients with diabetes mellitus. J Antimicrob Chemother 43: 305-307 [Abstract] [Full Text]